Anteris Technologies Ltd Stock Other OTC

Anteris Technologies Ltd is an Australia-based company that is engaged in the research and development (R&D) of its structural heart products. The Company is engaged in the manufacture and sale of ADAPT regenerative tissue products globally. It is focused on developing biomimetic transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis. ADAPT is the Company’s patented anti-calcification tissue technology. Its DurAVR THV is a three dimensional (3D) single piece valve and is a biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The Company also provides ComASUR Delivery System, a balloon expandable system with the ability to rotate valves for predictable alignment with the heart’s native commissure.